P2.01-043 PD-L1 Expression, EGFR and KRAS Mutations in First-Line Therapy (1L) for Non-Small Cell Lung Cancer (NSCLC) Patients
2017 ◽
Vol 12
(11)
◽
pp. S2085-S2086
◽
D. Cronin-Fenton
◽
T. Dalvi
◽
E. Hedgeman
◽
M. Norgaard
◽
L. Petersen
◽
...
2019 ◽
Vol 14
(10)
◽
pp. S398
◽
B. Han
◽
T. Chu
◽
X. Zhang
◽
H. Zhong
◽
B. Zhang
◽
...
Bruno Andreoni
◽
Gianmarco Contino
2016 ◽
Vol 7
(11)
◽
pp. 1515-1523
◽
Yi-Hsin Liang
◽
Yu-Yun Shao
◽
Bin-Chi Liao
◽
Ho-Sheng Lee
◽
James Chih-Hsin Yang
◽
...
2018 ◽
Vol 125
◽
pp. 273-281
◽
Shirish M. Gadgeel
◽
James P. Stevenson
◽
Corey J. Langer
◽
Leena Gandhi
◽
Hossein Borghaei
◽
...
Yi Chen
◽
Jinyu Li
◽
Shixue Chen
◽
Yibao Zhang
◽
Yi Hu
◽
...
2008 ◽
Vol 3
(3)
◽
pp. 303-310
◽
Thomas Fong
◽
Daniel Morgensztern
◽
Ramaswamy Govindan
2007 ◽
Vol 2
(8)
◽
pp. S693-S694
J Schiller
◽
S.R. Dakhil
◽
A.P. Lyss
◽
D.M. Loesch
◽
D Waterhouse
◽
...
2005 ◽
Vol 37
(6)
◽
pp. 332
Nam-Su Lee
◽
Hee-Sook Park
◽
Jong-Ho Won
◽
Dae-Sik Hong
◽
Su-Taek Uh
◽
...
2018 ◽
Vol 14
(2)
◽
pp. 67